The World Health Organization (WHO) Essential Medicines List (EML) defines minimum acceptable availability of 376 safe, affordable medicines. Over 150 countries use the EML to guide treatment decisions. However, its utility is hindered - the number of diseases addressed is limited and pathways to spread information are under-powered. As a result, billions of people in low- and middle-income countries (LMICs) have inadequate access to treatments for serious illnesses. Our program, Remedi, will uncover additional uses of EML medicines, and catalyze the EML’s global reach by enhancing its format, accessibility, and health worker awareness. We will make better use of what we have. We will systematically curate, validate, share, and locally implement existing and new therapeutic uses, prioritizing the most prevalent medicines for diseases with the highest current and projected future burden, affecting the most vulnerable and marginalized. Hundreds of millions of people will benefit from medicines already in local pharmacies.
Vanderbilt University Medical Centerwebsite: https://victr.vumc.org/
Charity, fund, non-governmental organization, religious institution, school, or other entity